# Precision Dosing of Busulfan in Children Undergoing HSCT

> **NCT04822532** · NA · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 260 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation
- Allogeneic Hematopoietic Stem Cell Transplantation
- Autologous Hematopoietic Stem Cell Transplantation

## Interventions

- **GENETIC:** GSTA1 genotyping

## Key facts

- **NCT ID:** NCT04822532
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-15
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04822532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04822532, "Precision Dosing of Busulfan in Children Undergoing HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04822532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*